SMS Pharmaceuticals Q3 Results

  • BSE: 532815
  • NSE: SMSPHARMA
  • ISIN: INE812G01025
  • Sector: Biotechnology & Drugs
BSE
204.052.95 (1.47%)
Volume18.93 K
Updated: Fri 24 May, 2024 | 15:28:28
NSE
204.53.25 (1.61%)
Volume1.43 L
Updated: Fri 24 May, 2024 | 15:29:57
Today: 198.70
206.75
52-Wk: 75.10
219.30

Q3 Results Highlights

  • Total Income
    ₹161.48 Cr.
    (8.52%)
  • Operating Profit
    ₹20.99 Cr.
    (102.02%)
  • Profit After Tax
    ₹11.48 Cr.
    (204.97%)
  • Operating Margin
    13.00%
    (86.16%)
Note: Comparison is on YoY basis

Quarterly - SMS Pharmaceuticals Q3 Results

*All figures in crores except per share values
Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
Total Revenue 161.48166.64-3.10%148.808.52%
Selling/ General/ Admin Expenses Total 14.0213.652.71%13.573.28%
Depreciation/ Amortization 8.017.901.38%8.12-1.43%
Other Operating Expenses Total 7.698.67-11.33%4.8159.85%
Total Operating Expense 140.49146.72-4.25%138.411.50%
Operating Income 20.9919.925.36%10.39102.02%
Net Income Before Taxes 16.5315.169.02%6.67147.87%
Net Income 11.4811.73-2.09%3.76204.97%
Diluted Normalized EPS 1.361.39-2.16%0.44209.09%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumFor youGet App